<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Inspire Pharmaceuticals, Inc.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New Jersey 22-3062052
--------------------------------------- ------------------------------------
(State of Incorporation or Organization) (I.R.S. Employer Identification no.)
15 Princess Road, Lawrenceville, NJ 08648
---------------------------------------- ------------
(Address of Principal Executive Office) (Zip Code)
If this form relates to the If this form relates to the
registration of a class of registration of a class of
securities pursuant to Section securities pursuant to
12(b) of the Exchange Act and is Section 12(g) of the Exchange
effective pursuant to General Act and is effective pursuant
Instruction A.(c), please check to General Instruction A.(d),
the following box. [_] please check the following box. [X]
Securities Act registration statement file number to which this form relates:
333-31171
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
------------------- ------------------------------
None
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock (par value $.001 per share)
----------------------------------------
(Title of Class)
1
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the Common Stock, par value $.001 per share, of Inspire
Pharmaceuticals, Inc. (the "Company"), to be registered hereunder is
incorporated by reference to the section entitled "Description of Securities" in
the prospectus forming a part of the Registration Statement on Form S-1, as
amended (Registration No. 333-31174), filed by the Company under the Securities
Act of 1933, as amended.
ITEM 2. EXHIBITS.
3.1 Amended and Restated Certificate of Incorporation (incorporated by
reference to Exhibit 3.1 to the Company's Registration Statement on Form S-1, as
amended (File No. 333-31174)).
3.2 Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2
to the Company's Registration Statement on Form S-1, as amended (File No. 333-
31174)).
4.1 Specimen Common Stock Certificate (incorporated by reference to
Exhibit 4.1 to the Company's Registration Statement on Form S-1, as amended
(File No. 333-31174)).
2
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
Inspire Pharmaceuticals, Inc.
By: /s/ Christy L. Shaffer
---------------------------
Christy L. Shaffer
President and
Chief Executive Officer
Date: July 24, 2000
3
